Antimicrobial susceptibility of periodontopathogenic bacteria

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1087-1091

  Kulik, Eva M ^a   Lenkeit, Krystyna ^a   Chenaux, Stephan ^a   Meyer, Jürg ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Aggregatibacter (Actinobacillus) actinomycetemcomitans; Etest; MIC; Porphyromonas gingivalis; Prevotella intermedia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN V; TETRACYCLINE;

ABSCESS; ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; MOUTH DISEASE; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PREVOTELLA NIGRESCENS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTI-BACTERIAL AGENTS; BACTEROIDACEAE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PERIODONTAL DISEASES; TIME FACTORS;

EID: 42149190571     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn079     Document Type: Article

References (40)

1. Ximénez-Fyvie LA, Haffajee AD, Socransky SS. Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis. J Clin Periodontol 2000; 27: 722-32.
2. Koriyama T, Karasawa T, Nakagawa K et al. Incidence of β-lactamase production and antimicrobial susceptibility of anaerobic Gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2001; 16: 10-5.
3. Slots J, Reynolds HS, Genco RJ. Actinobacillus actinomycetem-comitans in human periodontal disease: A cross-sectional microbiological investigation. Infect Immun 1980; 29: 1013-20.
4. Muller HP, Heinecke A, Fuhrmann A et al. Intraoral distribution of Actinobacillus actinomycetemcomitans in young adults with minimal periodontal disease. J Periodontal Res 2001; 36: 114-23.
5. van Winkelhoff AJ, Slots J. Actinobacillus actinomycetem-comitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999; 20: 122-35.
6. Brook I. Microbiology of polymicrobial abscesses and implications for therapy. J Antimicrob Chemother 2002; 50: 805-10.
7. Mombelli A, Samaranayake, LP. Topical and systemic antibiotics in the managementlof periodontal diseases. Int Dent J 2004; 54: 3-14.
8. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996; 10: 79-88.
9. van Winkelhoff AJ, Herrera Gonzales D, Winkel EG et al. Antimicrobial resistance in the subgingival microflora in patients with adult poriodontitis. A comparison between The Netherlands and Spain. J Cin Periodontol 2000; 27: 79-86.
10. Slots J. Selective medium for isolation of Actinobacillus actinomycetercomitans. J Clin Microbiol 1982; 15: 606-9.
11. Mombelli A. The use of antibiotics in periodontal therapy. In: Lindhe J, Kanning T, Lang NP, eds. Clinical Periodontology and Implant Dentistry. Oxford: Blackwell Munksgaard, 2003; 495-511.
12. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard, M11-A7. CLSI, Wayne, PA, USA, 2007.
13. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceplibility Testing of Infrequently Isolated or Fastidious Bacteria: Approved Guideline M46-A. CLSI, Wayne, PA, USA, 2006.
14. Gordon JM, Walker CB. Current status of systemic antibiotic usage in destructive periodontal disease. J Periodontol 1993; 64: 760-71.
15. Bahar H, Torun MM, Demirci M et al. Antimicrobial resistance and β-lactamase production of clinical isolates of Prevotella and Porphyromonas species. Chemotherapy 2005; 51: 9-14.
16. Kuriyama T, Williams DW, Yanagisawa M et al. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral Microbiol Immunol 2007; 22: 285-8.
17. van Winkelhoff AJ, Herrera D, Oteo A et al. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 2005; 32: 893-8.
18. Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol 1999; 26: 261-3.
19. Eick S, Pfister, W, Straube E. Antimicrobial susceptibility of anaerobic and capthophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. Int J Antimicrob Agents 1999; 12: 41-6.
20. Tribble GD, Lamont GJ, Progulske-Fox A et al. Conjugal transfer of chromosomal DNA contributes to genetic variation in the oral pathogen Porphyromonas gingivalis. J Bacteriol 2007; 189: 6382-8.
21. Maestro JR, Bascones A, Sanchez P et al. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter 2007; 20: 61-7.
22. Handal T, Olson I, Walker CB et al. β-Lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiol Immunol 2004; 19: 303-8.
23. Sobottka I, Cachovan G, Sturenburg E et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 2002; 46: 4019-21.
24. Walker CB, Karpinia K, Baehni P. Chemotherapeutics: Antibiotics and other antimicrobials. Periodontol 2000 2004; 36: 146-65.
25. Handal T, Olsen I, Walker CB et al. Detection and characterization of β-lactamase genes in subgingival bacteria from patients with refractory periodontitis. FEMS Microbiol Lett 2005; 242: 319-24.
26. Fosse T, Madinier I, Hitzig C et al. Prevalence of β-lactamase-producing strains among 149 anaerobic Gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 1999; 14: 352-7.
27. Madinler IM, Fosse TB, Hitzig C et al. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J Periodontol 1999; 70: 88-92.
28. Muller HP, Holdemeth S, Burkhardt U et al. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol 2002; 29: 736-42.
29. Edwards DI. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 1993; 31: 9-20.
30. Slots J. Systemic antibiotics in penodontics. J Periodontol 2004; 75: 1553-65.
31. Miyake Y, Tsuruda K, Okuda K et al. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidezole against periodontopathic bacteria. J Periodontal Res 1995; 30 290-3.
32. Guggenheim B, Guggenheim M, Gmur R et al. Application of the Zurich biofilm model to problems of cariology. Caries Res 2004; 38: 212-22.
33. Sedlacak MJ, Walker G. Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol 2007; 22: 333-9.
34. Rudney JD, Chen R, Sedgewick GJ. Intracallular Actinobacillus actinomycelemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001; 69: 2700-7.
35. Eick S, Pfiler W. Effidacy of antibiotics against penodontopathogenic bacteria within epithelial cells: An in vitro study. J Periodontol 2004; 75: 1327-34.
36. Bryskier A. Viridans group streptococci: A reservoir of resistant. bacteria in oral cavities. Clin Micrabiol Infect 2002; 8: 65-9.
37. Wang BY, Chi B, Kuramitsu HK. Genetic exchange between Troponema denticola and Streptococcus gordonii in biofilms. Oral Microbiol Immunol 2002; 17: 108-12.
38. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004; 12: 412-6.
39. Aas JA, Paster BJ, Stokes LN et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43: 5721-32.
40. Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional difference in outpatient antibiotic consumtion: Evidence from Switzerland. Health Policy 2006; 78: 77-92.